Infant immune response to hepatitis B vaccine after fetal exposure to telbivudine

References

• Global progress report on HIV, viral hepatitis and sexually transmitted infections. World Health Organization; 2021.
   Google Scholar
• Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepatitis. 2004;11(2):97–6. doi:10.1046/j.1365-2893.2003.00487.x.
   PubMed Web of Science ®Google Scholar
• Lee CGY, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunization in newborn infants of mothers positive for hepatitis B surface antigen: systemic review and meta-analysis. BMJ. 2006;332:332. doi:10.1136/bmj.38726.404120.7C.
   PubMedGoogle Scholar
• Chen H, Lin L, Hu F, Lee J, Lin W, Yang Y, Huang F, Wu S, Chen SC, Wen W, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology. 2012;142(4):773–781.e772. doi:10.1053/j.gastro.2011.12.035.
   PubMed Web of Science ®Google Scholar
• Wen W, Chang M, Zhao L, Ni Y-H, Hsu H-Y, Wu J-F, Chen P-J, Chen D-S, Chen H-L. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol. 2013;59(1):24–30. doi:10.1016/j.jhep.2013.02.015.
   PubMed Web of Science ®Google Scholar
• Zou H, Chen Y, Duan Z, Zhang H, Pan C. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepatitis. 2012;19(2):e18–25. doi:10.1111/j.1365-2893.2011.01492.x.
   PubMed Web of Science ®Google Scholar
• Funk A, Lu Y, Yoshida K, Zhao T, Boucheron P, van Holten J, Chou R, Bulterys M, Shimakawa Y. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(1):70–84. doi:10.1016/S1473-3099(20)30586-7.
   PubMed Web of Science ®Google Scholar
• Terrault N, Lok A, McMahon B, Chang K-M, Hwang JP, Jonas MM, Brown RS, Bzowej NH, Wong JB. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–99. doi:10.1002/hep.29800.
   PubMed Web of Science ®Google Scholar
• Pan C, Duan Z, Bhamidimarri K, Zou H, Liang X, Li J, Tong MJ. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol. 2012;10(5):452–59. doi:10.1016/j.cgh.2011.10.041.
   PubMed Web of Science ®Google Scholar
• Liver. EAftSot. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370–98. doi:10.1016/j.jhep.2017.03.021.
   PubMed Web of Science ®Google Scholar
• Pan C, Li M, Zeng H, Zhang Y, Cao W-H, Wang Y, Zhou M-F, Hu Y-H, Wan G, Xie Y, et al. Developmental consequences of prenatal telbivudine exposure during the third trimester. Clin Gastroenterol Hepatol. 2021;19(5):1061–63. doi:10.1016/j.cgh.2020.04.056.
   PubMed Web of Science ®Google Scholar
• Wang R, Nan Y. Telbivudine induced neutropenia in a patient with chronic hepatitis B: a case report. J Clin Hepatobiliary Dis. 2015;31:273–273.
   Google Scholar
• Bridges E, Selden J, Luo S. Nonclinical safety profile of telbivudine, a novel potent antiviral agent for treatment of hepatitis B. Antimicrob Agents Chemother. 2008;52(7):2521–28. doi:10.1128/aac.00029-08.
   PubMed Web of Science ®Google Scholar
• Jia J, Li L. Guidelines for prevention and treatment of chronic hepatitis B (2010 China). J Pract Liver Dis. 2011;1:7–21.
   Google Scholar
• McDonald R, McDonald J, Kallmes D, CarterR, Behind the numbers: propensity score analysis-a primer for the diagnostic radiologist. Radiology. Radiology. 2013;269(3):640–645. doi:10.1148/radiol.13131465.
   PubMed Web of Science ®Google Scholar
• Zoulim F, Locarnini S. Management of treatment failure in chronic hepatitis B. J Hepatol. 2012;56:S112–122. doi:10.1016/S0168-8278(12)60012-9.
   PubMed Web of Science ®Google Scholar
• Peng C, Chien R, Liaw Y. Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy. J Hepatol. 2012;57(2):442–50. doi:10.1016/j.jhep.2012.02.033.
   PubMed Web of Science ®Google Scholar
• Giles M, Visvanathan K, Sasadeusz J. Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding. Antivir Ther. 2011;16(5):621–28. doi:10.3851/imp1813.
   PubMed Web of Science ®Google Scholar
• Nachega J, Uthman O, Mofenson L, Anderson JR, Kanters S, Renaud F, Ford N, Essajee S, Doherty MC, Mills EJ, et al. Safety of tenofovir disoproxil fumarate-based antiretroviral therapy regimens in pregnancy for HIV-Infected women and their infants: a systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2017;76(1):1–12. doi:10.1097/qai.0000000000001359.
   PubMed Web of Science ®Google Scholar
• Han G, Cao M, Zhao W, Jiang H-X, Wang C-M, Bai S-F, Yue X, Wang G-J, Tang X, Fang Z-X, et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol. 2011;55(6):1215–21. doi:10.1016/j.jhep.2011.02.032.
   PubMed Web of Science ®Google Scholar
• Yao T, Shao Z, Wu L, Dong S, Gao L, Wu Y, Shi X, Shi J, Liu G, Wang J, et al. Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: a 3-year follow-up study in China. Vaccine. 2021;39(18):2537–44. doi:10.1016/j.vaccine.2021.03.074.
   PubMed Web of Science ®Google Scholar
• Liang X, Liu P, He Z, Chen X, and Xiao X. The effect of maternal use of telbivudine on neonatal CD4+CD25+ regulatory T cells for the prevention of mother-to-child transmission of hepatitis B virus. Clinics and Research in Hepatology and Gastroenterology. 2020; 44(2):195–203. doi:10.1016/j.clinre.2019.06.004
   PubMed Web of Science ®Google Scholar
• Ho C, Chang T, Chien R. Telbivudine on IgG-associated hypergammaglobulinemia and TGF-β1 hyperactivity in hepatitis B virus-related liver cirrhosis. PloS One. 2019;14(11):e0225482. doi:10.1371/journal.pone.0225482.
   PubMed Web of Science ®Google Scholar
• Zhang H, Pan C, Pang Q, Tian R, Yan M, Liu X. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. Hepatology. 2014;60(2):468–76. doi:10.1002/hep.27034.
   PubMed Web of Science ®Google Scholar
• Pan C, Han G, Jiang H, Zhao W, Cao M, Wang C, Yue X, Wang G. Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B. Clin Gastroenterol Hepatol. 2012;10(5):520–26. doi:10.1016/j.cgh.2012.01.019.
   PubMed Web of Science ®Google Scholar
• Han G, Jiang H, Wang C, Ding Y, Wang G-J, Yue X, Zhou L, Zhao W. Long-term safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy. J Viral Hepat. 2017;24(6):514–21. doi:10.1111/jvh.12670.
   PubMed Web of Science ®Google Scholar